3Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55:74-105.
4Kirchhoff C, Habben I, Ivell R, et al. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod, 1991, 45:350-357.
5Drapkin R, yon Horsten HH, Lin Y, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res, 2005, 65:2162-2169.
6Moore RG, Brown AK, Miller MC, et al. Utility of a novel selllnl tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus. Gynecol Oncol, 2008, l l0: 196-201.
7Colombo N, Preti E, Landoni F, et al. Endometrial cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up [J]. Ann Oncol, 2013, Suppl 6: vi33-38.
8Hellstrom I, Rayeraft J, Hayden-Ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma[J]. Cancer Res, 2003, 63: 3695-3700.
9Yang Z, Wei C, Luo Z, et al. Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis [J]. Onco Targets Ther,2013, 6: 957-966.
10Ferraro S, Braga F, Lanzoni M, et al. Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review[J]. J Clin Pathol, 2013, 66: 273-281.
